Nutrimed: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Nutrimed
Largest movements
- Current investments +€529,567
up €529,567 (+24.9%), from €2.1m to €2.7m
- Cash +€217,592
up €217,592 (+159%), from €136,755 to €354,347
mainly Net result for the year (+€630,478) and Stocks and contracts (+€158,725)
- Stocks and contracts -€158,725
down €158,725 (-26.7%), from €595,537 to €436,812
- Reserves +€630,478
up €630,478 (+21.4%), from €2.9m to €3.6m
- Trade debts -€40,010
down €40,010 (-69.2%), from €57,779 to €17,768
- Gross operating margin -€130,405
down €130,405 (-11.9%), from €1.1m to €966,027
- Taxes -€46,392
down €46,392 (-13.8%), from €335,990 to €289,598
- Financial income -€11,047
down €11,047 (-16.2%), from €68,036 to €56,989
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,333,188 | €3,892,154 | +€558,965 | +16.8% |
| Fixed assets | 21/28 | €309,328 | €286,622 | -€22,706 | -7.3% |
| Tangible fixed assets | 22/27 | €309,328 | €286,622 | -€22,706 | -7.3% |
| Land and buildings | 22 | €302,810 | €283,763 | -€19,046 | -6.3% |
| Plant, machinery and equipment | 23 | €5,788 | €2,590 | -€3,198 | -55.2% |
| Furniture and vehicles | 24 | €731 | €268 | -€462 | -63.3% |
| Current assets | 29/58 | €3,023,860 | €3,605,532 | +€581,672 | +19.2% |
| Stocks and contracts in progress | 3 | €595,537 | €436,812 | -€158,725 | -26.7% |
| Stocks | 30/36 | €595,537 | €436,812 | -€158,725 | -26.7% |
| Amounts receivable within one year | 40/41 | €167,198 | €156,649 | -€10,548 | -6.3% |
| Trade receivables | 40 | €165,564 | €153,542 | -€12,022 | -7.3% |
| Other amounts receivable | 41 | €1,634 | €3,107 | +€1,473 | +90.2% |
| Current investments | 50/53 | €2,123,581 | €2,653,148 | +€529,567 | +24.9% |
| Cash at bank and in hand | 54/58 | €136,755 | €354,347 | +€217,592 | +159% |
| Deferred charges and accrued income | 490/1 | €790 | €4,575 | +€3,785 | +479% |
| Total equity and liabilities | 10/49 | €3,333,188 | €3,892,154 | +€558,965 | +16.8% |
| Equity | 10/15 | €2,990,621 | €3,621,099 | +€630,478 | +21.1% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €2,940,621 | €3,571,099 | +€630,478 | +21.4% |
| Distributable reserves | 133 | €2,940,621 | €3,571,099 | +€630,478 | +21.4% |
| Amounts payable | 17/49 | €342,568 | €271,055 | -€71,513 | -20.9% |
| Amounts payable after more than one year | 17 | €237,361 | €214,984 | -€22,377 | -9.4% |
| Financial debts | 170/4 | €237,361 | €214,984 | -€22,377 | -9.4% |
| Amounts payable within one year | 42/48 | €105,207 | €56,071 | -€49,136 | -46.7% |
| Current portion of amounts payable after more than one year | 42 | €22,089 | €22,377 | +€288 | +1.3% |
| Trade debts | 44 | €57,779 | €17,768 | -€40,010 | -69.2% |
| Suppliers | 440/4 | €57,779 | €17,768 | -€40,010 | -69.2% |
| Taxes, remuneration and social security | 45 | €23,179 | €11,797 | -€11,382 | -49.1% |
| Taxes | 450/3 | €15,584 | €3,891 | -€11,693 | -75.0% |
| Remuneration and social security | 454/9 | €7,595 | €7,906 | +€311 | +4.1% |
| Other amounts payable | 47/48 | €2,160 | €4,129 | +€1,969 | +91.1% |
| Remuneration, social security and pensions | 62 | €67,593 | €69,260 | +€1,667 | +2.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,706 | €22,706 | = | 0.0% |
| Other operating charges | 640/8 | €4,194 | €4,200 | +€6 | +0.1% |
| Gross operating margin | 9900 | €1,096,432 | €966,027 | -€130,405 | -11.9% |
| Operating profit (loss) | 9901 | €1,001,939 | €869,860 | -€132,079 | -13.2% |
| Financial income | 75/76B | €68,036 | €56,989 | -€11,047 | -16.2% |
| Recurring financial income | 75 | €68,036 | €56,989 | -€11,047 | -16.2% |
| Financial charges | 65/66B | €6,631 | €6,773 | +€141 | +2.1% |
| Recurring financial charges | 65 | €6,631 | €6,773 | +€141 | +2.1% |
| Profit (loss) for the period before taxes | 9903 | €1,063,343 | €920,077 | -€143,267 | -13.5% |
| Income taxes | 67/77 | €335,990 | €289,598 | -€46,392 | -13.8% |
| Profit (loss) for the period | 9904 | €727,353 | €630,478 | -€96,875 | -13.3% |
| Profit (loss) for the period to be appropriated | 9905 | €727,353 | €630,478 | -€96,875 | -13.3% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.